EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts

Yvonne J M Campman, Martijn R Tannemaat iD, Annabel M Ruiter, Sarah Hoffmann iD

Muscle & Nerve · 2026-09 · 74 (S1)

DOI: 10.1002/mus.70080 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Muscle & Nerve, online erschienen am 01.07.2026. Verfasst von Yvonne J M Campman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Myasthenia Gravis, Fatigue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fatigue is a common, often disabling symptom in myasthenia gravis (MG), distinct from muscle fatigability, and strongly associated with reduced quality of life. This narrative review examines current evidence on fatigue in MG, its patient impact, and future research directions. Earlier studies, mostly small and heterogeneous, reported a highly variable prevalence of fatigue. Recent large registry‐based studies have now established a more consistent prevalence around 60% and confirmed associations with disease severity, depressive symptoms, and physical inactivity. Fatigue has also been assessed as secondary endpoint in phase 3 trials of targeted immunotherapies, with improvements paralleling broader clinical benefits. In contrast, non‐pharmacological approaches remain understudied; however, several studies have recently been initiated in which fatigue is a predefined outcome measure. Emerging biomarker evidence suggests that systemic low‐grade inflammation may contribute to fatigue. Together, these insights highlight the need for targeted, multidimensional strategies to better understand and treat fatigue in MG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisFatigueHumansQuality of LifeImmunotherapy

Stichwörter der Autor:innen

low‐grade inflammationnon‐pharmacological interventionspatient‐reported outcomesregistry‐based researchtargeted immunotherapy

Autor:innen und Institutionen

  • Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Neurology and Neuroscience Clinical Research Center (NCRC), Charité - Universitätsmedizin, Berlin, Germany.

ORCID-Profile: Martijn R Tannemaat, Sarah Hoffmann

Zitieren

APA

Campman, Y. J. M., Tannemaat, M. R., Ruiter, A. M., & Hoffmann, S. (2026). Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts. Muscle & Nerve, 74(S1). https://doi.org/10.1002/mus.70080

Vancouver

Campman YJM, Tannemaat MR, Ruiter AM, Hoffmann S. Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts. Muscle & Nerve. 2026;74(S1). doi:10.1002/mus.70080

BibTeX
@article{Campman2026,
  author = {Campman, Yvonne J M and Tannemaat, Martijn R and Ruiter, Annabel M and Hoffmann, Sarah},
  title = {Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {74},
  number = {S1},
  doi = {10.1002/mus.70080}
}
Kostenlos starten →